Hou, K. et al. Microbiota in health and diseases. Signal Transduct. Target. Ther. 7, 135 (2022).

Article  PubMed  PubMed Central  Google Scholar 

Chung, Y. et al. A synthetic probiotic engineered for colorectal cancer therapy modulates gut microbiota. Microbiome 9, 122 (2021).

Article  PubMed  PubMed Central  CAS  Google Scholar 

Sepich-Poore, G. D. et al. The microbiome and human cancer. Science 371, eabc4552 (2021).

Article  PubMed  PubMed Central  CAS  Google Scholar 

Byrd, A. L., Belkaid, Y. & Segre, J. A. The human skin microbiome. Nat. Rev. Microbiol. 16, 143–155 (2018).

Article  PubMed  CAS  Google Scholar 

Chen, Y. E., Fischbach, M. A. & Belkaid, Y. Skin microbiota–host interactions. Nature 553, 427–436 (2018).

Article  PubMed  PubMed Central  CAS  Google Scholar 

de Vos, W. M., Tilg, H., Van Hul, M. & Cani, P. D. Gut microbiome and health: mechanistic insights. Gut 71, 1020–1032 (2022).

Article  PubMed  Google Scholar 

Lavelle, A. & Sokol, H. Gut microbiota-derived metabolites as key actors in inflammatory bowel disease. Nat. Rev. Gastroenterol. Hepatol. 17, 223–237 (2020).

Article  PubMed  Google Scholar 

Lin, S. S. et al. Mucosal immunity-mediated modulation of the gut microbiome by oral delivery of probiotics into Peyer’s patches. Sci. Adv. 7, eabf0677 (2021).

Article  PubMed  PubMed Central  CAS  Google Scholar 

Wu, H.-J. & Wu, E. The role of gut microbiota in immune homeostasis and autoimmunity. Gut Microbes 3, 4–14 (2012).

Article  PubMed  PubMed Central  Google Scholar 

Roberts, N. J. et al. Intratumoral injection of Clostridium novyi-NT spores induces antitumor responses. Sci. Transl. Med. 6, 249ra111 (2014).

Article  PubMed  PubMed Central  Google Scholar 

Xu, W. et al. Attenuated Salmonella VNP20009 mutant (DeltahtrA) is a promising candidate for bacteria-mediated tumour therapy in hosts with TNFR1 deficiency. Lett. Appl. Microbiol. 67, 97–103 (2018).

Article  PubMed  CAS  Google Scholar 

Li, R. et al. Expressing cytotoxic compounds in Escherichia coli Nissle 1917 for tumor-targeting therapy. Res. Microbiol. 170, 74–79 (2019).

Article  PubMed  CAS  Google Scholar 

Jacouton, E. et al. Anti-tumoral effects of recombinant Lactococcus lactis strain secreting IL-17A cytokine. Front. Microbiol. 9, 3355 (2018).

Article  PubMed  Google Scholar 

Fan, J. X. et al. Bacteria-mediated tumor therapy utilizing photothermally-controlled TNF-alpha expression via oral administration. Nano. Lett. 18, 2373–2380 (2018).

Article  PubMed  CAS  Google Scholar 

Agarwal, P., Khatri, P., Billack, B., Low, W.-K. & Shao, J. Oral delivery of glucagon like peptide-1 by a recombinant Lactococcus lactis. Pharm. Res. 31, 3404–3414 (2014).

Article  PubMed  CAS  Google Scholar 

Anselmo, A. C., McHugh, K. J., Webster, J., Langer, R. & Jaklenec, A. Layer-by-layer encapsulation of probiotics for delivery to the microbiome. Adv. Mater. 28, 9486–9490 (2016).

Article  PubMed  PubMed Central  CAS  Google Scholar 

Duran-Lobato, M., Niu, Z. & Alonso, M. J. Oral delivery of biologics for precision medicine. Adv. Mater. 32, e1901935 (2020).

Article  PubMed  Google Scholar 

Oka, A. & Sartor, R. B. Microbial-based and microbial-targeted therapies for inflammatory bowel diseases. Dig. Dis. Sci. 65, 757–788 (2020).

Article  PubMed  PubMed Central  CAS  Google Scholar 

Toso, J. F. et al. Phase I study of the intravenous administration of attenuated Salmonella typhimurium to patients with metastatic melanoma. J. Clin. Oncol. 20, 142–152 (2002).

Article  PubMed  Google Scholar 

Fritz, S. E. et al. A phase I clinical study to evaluate safety of orally administered, genetically engineered Salmonella enterica serovar Typhimurium for canine osteosarcoma. Vet. Med. Sci. 2, 179–190 (2016).

Article  PubMed  PubMed Central  CAS  Google Scholar 

Cao, Z., Cheng, S., Wang, X., Pang, Y. & Liu, J. Camouflaging bacteria by wrapping with cell membranes. Nat. Commun. 10, 3452 (2019).

Article  PubMed  PubMed Central  Google Scholar 

Cao, Z., Lin, S. & Liu, J. Bacteria-based microdevices for the oral delivery of macromolecules. Pharmaceutics 13, 1610 (2021).

Article  PubMed  PubMed Central  CAS  Google Scholar 

Feng, P., Cao, Z., Wang, X., Li, J. & Liu, J. On-demand bacterial reactivation by restraining within a triggerable nanocoating. Adv. Mater. 32, e2002406 (2020).

Article  PubMed  Google Scholar 

Luo, H. et al. Chemical reaction-mediated covalent localization of bacteria. Nat. Commun. 13, 7808 (2022).

Article  PubMed  PubMed Central  CAS  Google Scholar 

Chowdhury, S. et al. Programmable bacteria induce durable tumor regression and systemic antitumor immunity. Nat. Med. 25, 1057–1063 (2019).

Article  PubMed  PubMed Central  CAS  Google Scholar 

Collins, J. H. & Young, E. M. Genetic engineering of host organisms for pharmaceutical synthesis. Curr. Opin. Biotechnol. 53, 191–200 (2018).

Article  PubMed  CAS  Google Scholar 

Danino, T. et al. Programmable probiotics for detection of cancer in urine. Sci. Transl. Med. 7, 289ra284 (2015).

Article  Google Scholar 

Hwang, I. Y. et al. Engineered probiotic Escherichia coli can eliminate and prevent Pseudomonas aeruginosa gut infection in animal models. Nat. Commun. 8, 15028 (2017).

Article  PubMed  PubMed Central  CAS  Google Scholar 

Hyun, J. et al. Engineered attenuated Salmonella typhimurium expressing neoantigen has anticancer effects. ACS Synth. Biol. 10, 2478–2487 (2021).

Article  PubMed  CAS  Google Scholar 

He, L. et al. Intestinal probiotics E. coli Nissle 1917 as a targeted vehicle for delivery of p53 and Tum-5 to solid tumors for cancer therapy. J. Biol. Eng. 13, 58 (2019).

Article  PubMed  PubMed Central  CAS  Google Scholar 

Geng, Z. et al. Aptamer-assisted tumor localization of bacteria for enhanced biotherapy. Nat. Commun. 12, 6584 (2021).

Article  PubMed  PubMed Central  CAS  Google Scholar